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Cyclic peptides are of considerable interest as
potential protein ligands. It has been postulated
that cyclicmoleculesmight bemore cell perme-
able than their linear counterparts due to their
reduced conformational flexibility. We report
a study that tests this hypothesis by using a
quantitative, reporter gene-based assay that
measures the relative cell permeability of ste-
roid conjugates of molecules of interest. We
demonstrate that cyclic peptides are, in fact,
not generally more permeable than their linear
counterparts.
INTRODUCTION
Cyclic peptides and depsipeptides have many interesting
biological activities [1–4]. They are usually more resistant
to proteolytic degradation than their linear isomers [5, 6].
In some cases, cyclic peptides may bind more tightly to
their protein targets due to their more restricted conforma-
tional flexibility [7, 8]. It has also been suggested that this
same reduction in conformational flexibility of cyclic pep-
tides should improve the cell permeability of these mole-
cules [6, 9–12]. However, few careful experimental tests
of the latter hypothesis have been published. Herein, we
report the synthesis of cyclic and linear peptide scaffolds
decorated with various side chains and test their relative
cell permeability by using a quantitative assay developed
recently in our laboratory [13]. We find that, at least for the
family of compounds explored here, cyclic molecules do
not exhibit significantly higher cell permeability than their
linear analogs.
The assay that we employed (shown schematically in
Figure S1 in the Supplemental Data available with this
article online) is a slight variation on a method reported
previously [13]. Briefly, a steroid conjugate of the molecule
of interest is incubated with cells that express high levels
of an artificial transactivator protein comprised of the Gal4
DNA-binding domain, the glucocorticoid receptor ligand-
binding domain, and the VP16 transactivation domain
(Gal4 DBD-GR LBD-VP16). The cells also contain a Gal4-
responsive firefly luciferase reporter gene (pG5B) and a
second reporter plasmid encoding Renilla reniformis lucif-
erase (pRL-SV40), which serves as a transfection control.Chemistry & Biology 14, 6Gal4 DBD-GR LBD-VP16 is a potentially potent transcrip-
tional activator, but, in the absence of a steroid ligand, it is
trapped in an inactive form by the high-affinity interaction
of Hsp90 with the GR LBD. If the steroid-containing chi-
mera is cell permeable, then its entry into the cell will result
in release of Gal4 DBD-GR LBD-VP16 from Hsp90 in a
dose-dependent fashion and subsequent induction of
firefly luciferase reporter gene expression. Note that there
is no evidence for facilitated diffusion of this class of ste-
roids; thus, the assay measures the extent to which the
molecule fused to the steroid impedes (or not) its passive
diffusion across the membrane. By comparing the IC50
values observed for different molecules conjugated to
the same steroid, their relative cell permeabilities can be
compared quantitatively after correcting for possible dif-
ferences in their affinity for the GR LBD. This is measured
for each molecule in vitro by using a competitive fluores-
cence polarization assay, as described [13].
RESULTS AND DISCUSSION
Synthesis of Cyclic and Linear Peptides
For this study, we created the compounds shown in Fig-
ure 1. Both termini of the linear peptides were capped to
prevent their ionization in aqueous solution and thus allow
them to be compared more fairly to their cyclic counter-
parts. First, we made cyclic (cyclo-[Glu(Fmoc)-Dpr(Alloc)-
Dpr(ivDde)-Dpr]-) and linear (Gln[Fmoc][Trt]-Dpr[Alloc]-
Dpr[ivDde]-Dpr[Ac]-) scaffolds on Rink amide resin (Alloc,
allyloxycarbonyl; ivDde, 1-[4,4-dimethyl-2,6-dioxocyclohex-
1-ylidene]-3-methylbutyl; Dpr, diaminopropionic acid).
These scaffolds have three chemically orthogonal protect-
ing groups: Fmoc, Alloc, and ivDde (Figure 2). This allows
stepwise deprotection and substitution at each step. The
scaffold approach is useful in that it avoids the problem
of variable cyclization yields for different linear precursors.
A cyclic scaffold was made on resin by selective cleavage
of acid-labile protecting groups (4-methyltrityl [Mtt] and 2-
phenylisopropyl [2-PhiPr]) with 1% TFA and subsequent
cyclization with benzotriazole-1-yl-oxy-tris-pyrrolidino-
phosphonium hexafluoro-phosphonate (PyBOP) and 7-
aza-1-hydroxybenzotriazole (HOAt) [14, 15]. Side chain
manipulation of cyclic and linear scaffolds was carried out
sequentially by the initial deprotection of the piperidine-la-
bile Fmoc and coupling with acids, followed by the depro-
tection of the hydrazine-labile ivDde [16] and coupling with
acids, and, finally, the deprotection of the Pd-labile Alloc71–677, June 2007 ª2007 Elsevier Ltd All rights reserved 671
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Cell Permeability of Cyclic and Linear PeptidesFigure 1. Chemical Structures of Cyclic
and Linear Peptides[17], followed by coupling with the dexamethasone deriva-
tive. The steroid that we employed in this study (SDex-
COOH) is different from those employed in our previous
experiments in which this assay was used [13, 18]. SDex-
COOH has a very high affinity for the GR LBD, making it
useful for the analysis of sparingly cell-permeable com-
pounds such as peptides (vide infra), and is compatible
with solid-phase synthesis [19]. The desired SDex-COOH
conjugates were purified by reverse-phase HPLC after
sequential manipulation as explained above (Figure 2).
Measurement of the In Vitro GR-Binding Affinities
First, we measured the in vitro GR-binding affinity of each
conjugate by using a fluorescence polarization-based as-
say that monitors displacement of a fluorescein-labeled
dexamethasone derivative from purified GR by the syn-
thetic conjugate. The IC50 values of each compound de-
rived from this analysis (Figure 3) were all in the high nano-
molar range (Table 1). The cyclic and the corresponding
linear peptides had similar GR-binding affinities, and the
GR-binding patterns were also quite similar in both series.
Luciferase Assays
Next, we carried out luciferase assays with HeLa cells that
had been transfected with a plasmid directing the expres-
sion of Gal4 DBD-GR LBD-VP16 as well as the constitutive
and Gal4-responsive luciferase reporter plasmids, as de-
scribed above. Luminescent intensities were measured
after incubating the cells for 40 hr with the compound of
interest (Figure 4). Gal4-responsive firefly luciferase activ-672 Chemistry & Biology 14, 671–677, June 2007 ª2007 Elseviity was normalized to the constitutive Renilla reniformis lu-
ciferase activity and then to the background signal to ob-
tain the EC50 values and maximum levels of induction from
the titration curves (see Table 1). The relative cell perme-
abilities were then gleaned from these data after correct-
ing for differences in GR LBD affinity, which were small.
Cyclic Peptides Are Not More Cell Permeable
than Their Linear Counterparts
In both the cyclic and linear peptide series, hydrophobic-
and aromatic-functionalized compounds (C/L1-2 and
C/L1-3) have lower EC50 values and higher maximum
fold induction, indicating that they are more cell perme-
able than the polar or charged compounds, as might
have been expected.
When the permeability measurements for the corre-
sponding cyclic and linear peptides were compared, the
simple cyclic peptide,C1-1, had an EC50 value of 41.8 mM,
while the corresponding linear peptide, L1-1, had an EC50
value of 8.1 mM, showing that the linear isomer is about 5.7
times more cell permeable than its cyclic counterpart. This
trend was also observed for the other isomeric pairs; the
linear molecule exhibited an apparent permeability that
was 2.0–6.2 times greater than that of its cyclic analog
regardless of the side chain moieties (see Table 1). Obvi-
ously, these results are inconsistent with the idea that
cyclic peptides are generally more permeable than their
linear counterparts due to reduced freedom of conforma-
tion [6, 10]. It is important to point out that, under the con-
ditions of the assay, both the linear and cyclic peptideser Ltd All rights reserved
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Cell Permeability of Cyclic and Linear PeptidesFigure 2. Synthesis of Cyclic and Linear Peptideswere quite stable. Mass spectrometry was employed to
monitor the level of each peptide relative to a proteolyti-
cally insensitive internal standard, and the data showed
no more than a 5% loss of the parent compounds over
the course of the assay, and most or all of this could be ex-
plained by the noise in the measurement (data not shown).
There was no significant difference between the stability
of the linear and cyclic peptides.
We also synthesized SDex-COOH derivatives (C/L-AA
and C/L-AF) of peptides lacking amide functionality in
their side chains as analogs ofC/L1-1 andC/L1-3. Gener-
ally, internal and intramolecular hydrogen bond potential
is thought to be critical for passive membrane permeabil-
ity [7–10], and it may be that the propensity of side chain
amides and main chain amides to form intramolecular
hydrogen bonds might be different in linear and cyclic
molecules, thus justifying a comparison. The data (Figures
S4 and S7) reveal that, again, there is little difference in the
relative cell permeabilities of the analogous linear andChemistry & Biology 14, 67cyclic molecules (C/L-AA and C/L-AF), further buttress-
ing the conclusion reached.
While not the focus of this study, it is interesting to note
that L1-1 and L1-3 had EC50 values of 8.1 mM and
0.84 mM, respectively, while the related compounds
L-AA and L-AF had EC50 values of 36.5 mM and
62.2 mM, respectively. These data indicate that L1-1 and
L1-3 are much more cell permeable than their analogs,
L-AA and L-AF. These data may suggest that side chain
amides of linear peptides are able to form intramolecular
hydrogen bonds that facilitate cell permeability.
However, more directed studies of compounds designed
to test this specific hypothesis would be required in order
to make general statements of this type.
Validation of the Luciferase Assay System
by a Fluorescence Microscopy Assay
To further validate our luciferase assay system, we took
advantage of conventional fluorescence microscopy1–677, June 2007 ª2007 Elsevier Ltd All rights reserved 673
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Cell Permeability of Cyclic and Linear Peptides[13]. We chose to compare two pairs with a relatively
high (C/L1-3) and low (C/L1-4) permeability difference, re-
spectively. Two fluorescein-labeled cyclic and linear pep-
tide pairs (C/L1-3-FL and C/L1-4-FL) were synthesized
by the attachment of an acetyl-ethyleneglycol-ethyl-
amine (AEEA) linker and then carboxyfluorescein instead
of SDex-COOH (Figure S8). HeLa cells were incubated
with 20 mM of the fluorescein-labeled compound or car-
boxyfluorescein as a control for 4 hr. The fluorescence im-
ages were taken after the cells were washed with 13 PBS,
fixed with 4% formaldehyde, and mounted with VECTA-
SHIELD medium containing 40,6-diamidino-2-phenylin-
dole (DAPI). The results showed that all compounds are
quite cell permeable (Figure S9). While the fluorescence
microscopy assays are poorly quantitative and the cell
permeability differences encountered with our assay
system are also relatively small, this similarity in the bright-
ness of the images of cells treated with fluorescein-
labeled cyclic and linear peptides is consistent with the
data obtained by using our method.
Figure 3. Fluorescence Polarization Data for Measurement of
In Vitro GR-Binding Affinity
(A) Data for cyclic peptides.
(B) Data for linear peptides.
The displacement of a fluorescein-labeled dexamethasone was mon-
itored by a decrease in fluorescence polarization. The data were plot-
ted as the millipolarization units (mP) versus the concentration of the
competitors. Derived IC50 values are shown in Table 1.674 Chemistry & Biology 14, 671–677, June 2007 ª2007 ElseviEvaluation of Physicochemical Properties
Several physicochemical properties, including molecular
size/volume, hydrophobicity, hydrogen bond potential,
polar surface area, desolvation energy, solubility, etc. have
been considered as contributors to cell permeability [20–
23]. Among these, particular importance has been placed
on the desolvation of hydrated hydrogen bonds in explain-
ing the differences in the permeability between linear and
cyclic peptides. This is because the gross physical prop-
erties of cyclic and linear peptides of the same sequence
are almost identical and thus are unlikely to explain any
large degree of difference in their permeabilities. However,
the presumably different conformational preferences of
these molecules could easily lead to a large difference in
internal hydrogen bonding and thus the amount of desol-
vation required to pass from the aqueous phase into a lipid
membrane. For example, Rezai et al. investigated the
relationship between the conformation and membrane
permeability of cyclic peptides by using a parallel artificial
membrane permeability assay (PAMPA) [24], an NMR
study, and computational modeling [10]. They were able
to develop a model in which conformation-dependent in-
tramolecular hydrogen bonding could explain the different
apparent permeabilities of various cyclic peptides [9].
They suggested that a similar argument could be made
to rationalize a single example they presented of a cyclic
peptide that was much more permeable than its linear
counterpart (in the PAMPA assay). It seems clear that more
intramolecular hydrogen bonding would indeed increase
cell permeability. However, in addressing the major point
of this paper, the real question is whether cyclic peptides
will generally have a greater amount of intramolecular
hydrogen bonding than linear peptides. From the results
presented here, it would seem that the answer is no. We
emphasize that detailed conformational studies have not
been done on the peptides employed in this study, so any
discussion of the degree of intramolecular hydrogen
bonding would be quite speculative. Nonetheless, the re-
sults are quite clear and show that the cyclic peptides
studied here are not more permeable than their linear
counterparts. Since the linear and cyclic molecules used
here have very similar partition coefficients, total polar sur-
face areas, etc., and have similar cell permeabilities, one
is forced to conclude that they do not differ drastically in
the degree of intramolecular hydrogen bonding. There-
fore, the hypothesis that cyclic peptides will, in general,
be easier to desolvate than linear peptides does not seem
to be true.
SIGNIFICANCE
Weassessed quantitatively the relative cell permeabil-
ity of comparable steroid conjugates of cyclic and lin-
ear peptides by using a reporter gene-based assay in
HeLa cells. We find no evidence that indicates that the
cyclic molecules are generally more cell permeable.
Indeed, the opposite appears to be true, although in
no case is the difference very large. Cyclic peptideser Ltd All rights reserved
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c (mM) Relative Permeability Factord
C1-1 41.8 ± 6.3 2711 ± 246 148 ± 22
C1-2 6.1 ± 0.8 3020 ± 128 79 ± 4
C1-3 6.3 ± 1.1 2690 ± 114 124 ± 16
C1-4 23.5 ± 6.6 2724 ± 358 173 ± 8
C1-5 24.4 ± 7.5 1643 ± 241 137 ± 9
C1-6 13.0 ± 2.0 2054 ± 120 230 ± 26
C5-6 10.2 ± 2.3 433 ± 36 193 ± 24
L1-1 8.1 ± 2.8 1463 ± 142 164 ± 30 5.7
L1-2 3.0 ± 0.4 3722 ± 136 79 ± 6 2.0
L1-3 0.84 ± 0.1 3125 ± 82 102 ± 10 6.2
L1-4 16.5 ± 5.5 1849 ± 209 270 ± 26 2.2
L1-5 4.7 ± 1.7 1731 ± 169 112 ± 21 4.2
L1-6 3.8 ± 0.5 1518 ± 56 295 ± 68 4.4
L5-6 3.2 ± 1.3 1401 ± 137 233 ± 26 3.8
C-AA 21.2 ± 6.6 1497 ± 109 141 ±14
C-AF 94.2 ± 37 1781 ±288 38 ± 4
L-AA 36.5 ± 7.8 2240 ±135 97 ± 11 0.40
L-AF 62.2 ± 18 1242 ± 127 67 ±10 2.7
a As references, SDex-CONH2: EC50 = 2.8 mM, IC50 = 36.3 nM; isobutyl amide of SDex-COOH (SDex-CO-IBA): EC50 = 567 nM,
IC50 = 14.1 nM (see Figures S3 and S6).
b Data from luciferase assays.
c Data from in vitro GR-binding assays.
d The relative permeability of linear peptides compared to the corresponding cyclic peptides, when combined with in vitro GR-
binding affinity; for example, (EC50[C1-1]/EC50[L1-1])/(IC50[C1-1]/IC50[L1-1]).remain a potentially intriguing class of protein ligands
due to their enhancedproteolytic stability and thehope
that they might exhibit tighter binding to proteins than
linear peptides; however, they cannot be relied upon to
exhibit greater cell permeability.
EXPERIMENTAL PROCEDURES
Synthesis of the Cyclic Peptide Scaffold on the Resin
The synthesis of the cyclic peptide scaffold was performed by employ-
ing conventional peptide coupling chemistry. Rink amide AM resins in
DMF were allowed to swell at room temperature for 1 hr. After DMF
was drained, the beads were incubated with 20% piperidine for
30 min. The beads were thoroughly washed with DMF (8 3 3 ml) and
then treated with Fmoc-Dpr(Mtt)-OH (2 eq.), HBTU (1.95 eq.), HOBt
(1.95 eq.), and DIPEA (10 eq.) in DMF for 1.5 hr. After deprotection of
Fmoc group with 20% piperidine, the beads were similarly coupled
with Fmoc-Dpr(ivDde)-OH (2 eq.). In order to reduce possible migra-
tion of ivDde to the a-amine group during Fmoc deprotection, the
resins were treated twice, for 15 min each, with 50% morpholine in
DMF. After being washed with DMF, the resins were suspended in
DCM containing Fmoc-Dpr(Alloc)-OH (2 eq.) and DIPEA (10 eq.). After
PyBOP (2 eq.) was added to the slurry at 40C, it was agitated for
30 min at 40C, then for 2 hr at room temperature. After deprotection
of Fmoc with 20% piperidine, the resins were coupled with Fmoc-
Glu(O-2-PhiPr)-OH (2 eq.). Both Mtt and 2-PhiPr groups were depro-
tected with 1% TFA and 2% triisopropylsilane in DCM. After the resinsChemistry & Biology 14, 6were thoroughly washed with both 5% DIPEA in DCM and DCM alone
they were dried in vacuo for 2 hr. Cyclization was carried out with
PyBOP (3 eq.), HOAt (3eq.), and DIPEA (10 eq.) in DMF and was per-
formed twice (for 24 hr each time). The cyclic scaffold was confirmed
by MALDI-MS [899 (M + H)+] after cleavage from the resin.
Synthesis of the Linear Peptide Scaffold on the Resin
The synthesis of the linear peptide scaffold was similarly performed by
employing conventional peptide coupling chemistry. Rink amide AM
resins in DMF were allowed to swell at room temperature for 1 hr. After
DMF was drained, the beads were incubated with 20% piperidine for
30 min. The beads were thoroughly washed with DMF (8 3 3 ml) and
then treated with Fmoc-Dpr(Mtt)-OH (2 eq.), HBTU (1.95 eq.), HOBt
(1.95 eq.), and DIPEA (10 eq.) in DMF for 1.5 hr. The Mtt group was re-
moved with 1% TFA and 2% triisopropylsilane in DCM. After the resins
were thoroughly washed with both 5% DIPEA in DCM and DCM alone,
they were treated with acetic anhydride (20 eq.) and DIPEA (20 eq.) for
2 hr. After deprotection of the Fmoc group with 20% piperidine, the
beads were similarly coupled with Fmoc-Dpr(ivDde)-OH (2 eq.). In or-
der to reduce possible migration of ivDde to the a-amine group during
Fmoc deprotection, the resins were treated twice, for 15 min each, with
50% morpholine in DMF. After being washed with DMF, the resins were
suspended in DCM containing Fmoc-Dpr(Alloc)-OH (2 eq.) and DIPEA
(10 eq.). After PyBOP (2 eq.) was added to the slurry at 40C, it was
agitated for 30 min at 40C, then for 2 hr at room temperature. After
deprotection of Fmoc with 20% piperidine, the resins were coupled
with Fmoc-Gln(Trt)-OH (2 eq.). The linear scaffold was confirmed by
MALDI-MS [958 (M + H)+] after cleavage from the resin.71–677, June 2007 ª2007 Elsevier Ltd All rights reserved 675
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Peptide Conjugates
SDex-CO-C/L peptide conjugates were synthesized by sequential
deprotection of Fmoc, ivDde, and Alloc groups and conventional pep-
tide coupling after each deprotection step by using cyclic or linear
scaffolds on the resin. Fmoc was removed by using 20% piperidine
in DMF for 30 min, and ivDde was removed by using 2% hydrazine
and 50% allyl alcohol in DMF (this was performed twice for 10 min each
time). Alloc was deprotected by PdCl2(PPh3)2 (0.1 eq.), acetic acid
(3.5 eq.), and tributyltin hydride (3 eq.) in DCM (this was performed
twice for 30 min each time), and the resins were then thoroughly
washed with DCM (3 3 3 ml), 10% TEA in DCM (3 3 3 ml), DCM
(3 3 3 ml), CH3OH (3 3 3 ml), and DCM (3 3 3 ml). After each depro-
tection, each acid (5 eq.) was coupled with HATU (5 eq.), HOAt
(5 eq.), DIPEA (10 eq.), and 2,6-lutidine (7 eq.) in DMF for 1.5 hr, and
the acetyl group was introduced by using acetic anhydride (20 eq.)
and DIPEA (20 eq.) in DMF for 2 hr. At the final step, SDex-COOH
(2.5 eq.) was coupled with HATU (2.5 eq.), HOAt (2.5 eq.), DIPEA
(10 eq.), and 2,6-lutidine (7 eq.) in DMF for 1.5 hr. The desired products
were released from the resins by using 95% TFA containing 2.5% trii-
sopropylsilane and 2.5% water and were purified by reverse-phase
Figure 4. Dose-Dependent Induction of Luciferase Expres-
sion
(A) Data for cyclic peptides.
(B) Data for linear peptides.
Luminescent intensities were measured 40 hr after treatment of each
compound at various concentrations with a dual-luciferase reporter
assay system. The data were plotted as the fold induction of luciferase
activities versus the concentration of the compounds. EC50 values
derived from these data are summarized in Table 1.676 Chemistry & Biology 14, 671–677, June 2007 ª2007 ElsevierHPLC. The structures of SDex-CO-C/L peptide conjugates were con-
firmed by MALDI-TOF analysis. MS (MALDI-TOF): m/z: C1-1: calcd for
C43H61FN8NaO12S 955.4, found 955.4 [M + Na]
+; C1-2: calcd for
C49H71FN8NaO12S 1037.5, found 1037.4 [M + Na]
+; C1-3: calcd
for C49H65FN8NaO12S 1031.4, found 1031.4 [M + Na]
+; C1-4: calcd
for C43H61FN8NaO13S 971.4, found 971.5 [M + Na]
+; C1-5: calcd for
C43H62FN9NaO12S 970.4, found 970.4 [M + Na]
+; C1-6: calcd for
C45H63FN8NaO14S 1013.4, found 1013.5 [M + Na]
+; C5-6: calcd
for C45H64FN9NaO14S 1028.4, found 1028.6 [M + Na]
+; L1-1: calcd for
C45H66FN9NaO13S 1014.4, found 1014.2 [M + Na]
+; L1-2: calcd for
C51H76FN9NaO13S 1096.5, found 1096.5 [M + Na]
+; L1-3: calcd
for C51H70FN9NaO13S 1090.5, found 1090.2 [M + Na]
+; L1-4: calcd
for C45H66FN9NaO14S 1030.4, found 1030.3 [M + Na]
+; L1-5: calcd for
C45H67FN10NaO13S 1029.4, found 1029.4 [M + Na]
+; L1-6: calcd
for C47H68FN9NaO15S 1072.4, found 1072.5 [M + Na]
+; L5-6: calcd
for C47H69FN10NaO15S 1087.5, found 1087.3 [M + Na]
+.
Synthesis of C-AA, C-AF, L-AA, and L-AF
Compounds C-AA, C-AF, L-AA, and L-AF were synthesized by using
Fmoc-Ala-OH or Fmoc-Phe-OH instead of Fmoc-Dpr(ivDde)-OH or
Fmoc-Dpr(Alloc)-OH under conditions similar to those employed for
the synthesis of cyclic or linear peptide scaffolds. The final products
were also cleaved from the resins by using 95% TFA containing 2.5%
triisopropylsilane and 2.5% water and were purified by reverse-phase
HPLC. Their structures were confirmed by MALDI-TOF analysis.
MS (MALDI-TOF): m/z: C-AA: calcd for C39H55FN6NaO10S 841.4,
found 841.5 [M + Na]+;C-AF: calcd for C45H59FN6NaO10S 917.4, found
917.5 [M + Na]+; L-AA: calcd for C41H60FN7NaO11S 900.4, found 900.4
[M + Na]+; L-AF: calcd for C47H64FN7NaO11S 976.4, found 976.5
[M + Na]+.
Concentration Determination of SDex-COOH Conjugates
SDex-COOH conjugates were dissolved in DMSO. The concentration
of each compound was determined by the distinct absorbance of
dexamethasone at 242 nm with an extinction coefficient of 1.2 3 104
M1cm1.
In Vitro Competition GR-Binding Assays
The GR-binding affinity was determined by using the glucocorticoid
receptor Competitor Assay Kit (Invitrogen). SDex-COOH conjugates
were mixed with 1 nM fluormone and 4 nM recombinant human gluco-
corticoid receptor in 100 ml buffer and were incubated in the dark at
25C for 1.5 hr. Fluorescence polarization was measured on a Panvera
Beacon 2000 fluorometer (Invitrogen). The concentration of a SDex-
COOH conjugate that results in a half-maximum decrease in the polar-
ization value is defined as the IC50 of the compound, which is a
measure of the relative binding affinity of the test compound for gluco-
corticoid receptor. The binding data were fit to the equation (P = [1C/
(IC50 + C)] 3 [Pmax  Pmin] + Pmin) where C is the concentration of the
test compound, P is the polarization of the sample, Pmax is the polari-
zation value observed when no competitor is added to the glucocorti-
coid receptor-fluormone complex, and Pmin is the polarization value
that represents maximum competition and was measured when 1 mM
dexamethasone was used as the glucocorticoid receptor competitor.
Luciferase Assays
HeLa cells (2.03 104 cells/well) were split in 96-well plates and main-
tained at 37C under 5% CO2 in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% (vol/vol) fetal calf serum. After 1 day,
cells were transfected in OPTI-MEM I medium by the Lipofectamine
Plus method (Invitrogen) with 0.101 mg total DNA, including 0.05 mg
Gal4 DBD-GR LBD-VP16, 0.05 mg pG5B reporter plasmid, and 1 ng
Renilla reniformis luciferase plasmid (pRL-SV40), which were prepared
as previously mentioned [13]. After DNA transfection, cells were main-
tained at 37C under 5% CO2 for 3 hr. Cells in DMEM were treated with
SDex-COOH conjugates dissolved in DMSO at various concentra-
tions. Luciferase assays were conducted 40 hr after treatment of each
compound with a dual-luciferase reporter assay system (Promega).Ltd All rights reserved
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Cell Permeability of Cyclic and Linear PeptidesThe luminescence was measured on a Sirius luminometer (Berthold
detection systems). The value obtained was normalized with respect
to the Renilla reniformis luciferase luminescence. The result for the
control cells to which no ligand was added was treated as 1, the base-
line for the induction. Other results were normalized based on this
baseline and finally presented as the fold of inductions. The concentra-
tion of the SDex-COOH conjugate that results in a half-maximum
increase of the induction level is defined as EC50. The maximum induc-
tion level is defined as INDmax. The induction data were fit to the equa-
tion (I = [C/(EC50 + C)] 3 [INDmax  1] + 1), where I is the fold of induc-
tion and C is the concentration of the test compound.
Supplemental Data
Supplemental Data include the schematic illustration of the design of
the cell permeability assay; the figures for fluorescence polarization
assays and luciferase assays of SDex-CONH2, SDex-CO-IBA, C-AA,
C-AF, L-AA, and L-AF; and the synthesis and fluorescence micros-
copy assays of fluorescein-labeled cyclic and linear peptides (C1-3-
FL, C1-4-FL, L1-3-FL, and L1-4-FL) and are available at http://
www.chembiol.com/cgi/content/full/14/6/671/DC1/.
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